Elanco Animal Health (ELAN) Capital Expenditures (2017 - 2026)
Elanco Animal Health (ELAN) posted Capital Expenditures of $51.0 million for Q1 2026, down 17.74% sequentially from $62.0 million in Q4 2025, and down 21.54% YoY from $65.0 million in Q1 2025.
Elanco Animal Health (ELAN) Capital Expenditures (2017 - 2026) Analysis & Trends
Elanco Animal Health has reported Capital Expenditures for 10 years, with the latest figure at $51.0 million in Q1 2026.
- Quarterly Capital Expenditures fell 21.54% year-over-year to $51.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $262.0 million (up 39.36% YoY) and the FY2025 annual result came in at $276.0 million, up 87.76% from the prior year.
- Capital Expenditures fell to $51.0 million in Q1 2026 per ELAN's latest filing, from $62.0 million in the prior quarter.
- Over five years, Capital Expenditures peaked at $92.0 million in Q3 2025 and troughed at $7.0 million in Q1 2022.
- A 5-year average of $46.2 million and a median of $42.0 million in 2023 frame the typical range for Capital Expenditures.
- The widest YoY moves for Capital Expenditures: up 3700.0% in 2022, down 61.11% in 2022.
- Over 5 years, Capital Expenditures stood at $77.0 million in 2022, then sank by 46.75% to $41.0 million in 2023, then increased by 14.63% to $47.0 million in 2024, then soared by 31.91% to $62.0 million in 2025, then retreated by 17.74% to $51.0 million in 2026.
- According to Business Quant data, Capital Expenditures over the past three periods registered $51.0 million, $62.0 million, and $92.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 104.00 Mn |
| 3 | Zoetis | 31.79 Bn | 30.11 Bn | 1.05 Bn | 117.00 Mn |
| 4 | Takeda Pharmaceutical | 28.69 Bn | 22.89 Bn | 5.10 Bn | -337.60 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.58 Bn | 683.80 Mn | 108.00 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 52.80 Mn |
| 7 | Neurocrine Biosciences | 15.58 Bn | 15.19 Bn | 935.80 Mn | 7.80 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 33.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Alkermes | 8.15 Bn | 7.49 Bn | 397.90 Mn | 8.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 33.00 Mn |
| Jun 30, 2026 | 33.00 Mn |
| Mar 31, 2026 | 51.00 Mn |
| Mar 31, 2026 | 51.00 Mn |
| Dec 31, 2025 | 62.00 Mn |
| Dec 31, 2025 | 62.00 Mn |
| Sep 30, 2025 | 92.00 Mn |
| Sep 30, 2025 | 92.00 Mn |
| Jun 30, 2025 | 57.00 Mn |
| Jun 30, 2025 | 57.00 Mn |
| Mar 31, 2025 | 65.00 Mn |
| Mar 31, 2025 | 65.00 Mn |
| Dec 31, 2024 | 47.00 Mn |
| Dec 31, 2024 | 47.00 Mn |
| Sep 30, 2024 | 42.00 Mn |
| Sep 30, 2024 | 42.00 Mn |
| Jun 30, 2024 | 34.00 Mn |
| Jun 30, 2024 | 34.00 Mn |
| Mar 31, 2024 | 24.00 Mn |
| Mar 31, 2024 | 24.00 Mn |